» Articles » PMID: 32075165

Photochemical Internalization for Intracellular Drug Delivery. From Basic Mechanisms to Clinical Research

Overview
Journal J Clin Med
Specialty General Medicine
Date 2020 Feb 21
PMID 32075165
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Photochemical internalisation (PCI) is a unique intervention which involves the release of endocytosed macromolecules into the cytoplasmic matrix. PCI is based on the use of photosensitizers placed in endocytic vesicles that, following light activation, lead to rupture of the endocytic vesicles and the release of the macromolecules into the cytoplasmic matrix. This technology has been shown to improve the biological activity of a number of macromolecules that do not readily penetrate the plasma membrane, including type I ribosome-inactivating proteins (RIPs), gene-encoding plasmids, adenovirus and oligonucleotides and certain chemotherapeutics, such as bleomycin. This new intervention has also been found appealing for intracellular delivery of drugs incorporated into nanocarriers and for cancer vaccination. PCI is currently being evaluated in clinical trials. Data from the first-in-human phase I clinical trial as well as an update on the development of the PCI technology towards clinical practice is presented here.

Citing Articles

Recent Advances in Nanoenzymes Based Therapies for Glioblastoma: Overcoming Barriers and Enhancing Targeted Treatment.

Wang L, Gu M, Zhang X, Kong T, Liao J, Zhang D Adv Sci (Weinh). 2025; 12(10):e2413367.

PMID: 39854126 PMC: 11905078. DOI: 10.1002/advs.202413367.


Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids.

Allen R, Yokota T Molecules. 2025; 29(24.

PMID: 39770086 PMC: 11677605. DOI: 10.3390/molecules29245997.


Enhancing the Efficacy of Radiation Therapy by Photochemical Internalization of Fibrin-Hydrogel-Delivered Bleomycin.

Laurel S, Gupta K, Nguyen J, Chandekar A, Le J, Berg K Cancers (Basel). 2024; 16(23).

PMID: 39682215 PMC: 11640518. DOI: 10.3390/cancers16234029.


Photodynamic Therapy for Oral Squamous Cell Carcinoma: Current Status, Challenges, and Prospects.

Zhang W, Chen S, Bai Z, Gan M, Chen M, Zhang Y Int J Nanomedicine. 2024; 19:10699-10710.

PMID: 39464676 PMC: 11512526. DOI: 10.2147/IJN.S481901.


Tailoring biomaterials for vaccine delivery.

Zhuo Y, Zeng H, Su C, Lv Q, Cheng T, Lei L J Nanobiotechnology. 2024; 22(1):480.

PMID: 39135073 PMC: 11321069. DOI: 10.1186/s12951-024-02758-0.


References
1.
Liu M . A Comparison of Plasmid DNA and mRNA as Vaccine Technologies. Vaccines (Basel). 2019; 7(2). PMC: 6631684. DOI: 10.3390/vaccines7020037. View

2.
Berg K, Madslien K, Bommer J, OFTEBRO R, Winkelman J, Moan J . Light induced relocalization of sulfonated meso-tetraphenylporphines in NHIK 3025 cells and effects of dose fractionation. Photochem Photobiol. 1991; 53(2):203-10. DOI: 10.1111/j.1751-1097.1991.tb03924.x. View

3.
Story W, Sultan A, Bottini G, Vaz F, Lee G, Hopper C . Strategies of airway management for head and neck photo-dynamic therapy. Lasers Surg Med. 2013; 45(6):370-6. DOI: 10.1002/lsm.22149. View

4.
Rajagopal A, Simon S . Subcellular localization and activity of multidrug resistance proteins. Mol Biol Cell. 2003; 14(8):3389-99. PMC: 181575. DOI: 10.1091/mbc.e02-11-0704. View

5.
Folini M, Berg K, Millo E, Villa R, Prasmickaite L, Daidone M . Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase. Cancer Res. 2003; 63(13):3490-4. View